MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
EYEN Eyenovia
- 0.085
- -0.005-5.22%
Close Dec 20 16:00 ET
- 0.087
- +0.002+1.76%
Post 19:58 ET
9.50MMarket Cap-0.12P/E (TTM)
0.095High0.083Low14.36MVolume0.083Open0.090Pre Close1.28MTurnover14.07%Turnover RatioLossP/E (Static)111.43MShares2.57052wk High2.58P/B8.71MFloat Cap0.07752wk Low--Dividend TTM102.08MShs Float10.740Historical High--Div YieldTTM13.00%Amplitude0.077Historical Low0.088Avg Price1Lot Size
About Eyenovia Company
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Company Profile
SymbolEYEN
Company NameEyenovia
Listing DateJan 25, 2018
Issue Price10.00
Founded2014
CEOMr. Michael M. Rowe
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address295 Madison Avenue,Suite 2400
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-833-393-6684
Websitehttp://www.eyenovia.com
Company Executives
- Name
- Position
- Salary
- Michael M. Rowe
- Chief Financial Officer, Treasurer, Secretary, Chief Executive Officer and Director
- 775.47K
- Bren Kern
- Chief Operating Officer
- 566.99K
- Dr. Tsontcho Ianchulev, M.D.
- Executive Chairman of the Board
- 247.50K
- Ellen R. Strahlman, M.D.
- Independent Director
- 162.50K
- Michael S. Geltzeiler
- Independent Director
- 57.83K
- Charles E. Mather, IV
- Independent Director
- 148.75K
- Dr. Ram Palanki
- Independent Director
- 140.00K
- Rachel Jacobson
- Independent Director
- 145.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.